CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for LEO Pharma A/S is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

LEO Pharma A/S
Industriparken 55
Phone: +45 4494-5888p:+45 4494-5888 Ballerup, DK-2750  Denmark Fax: +45 7226-3321f:+45 7226-3321
Business Summary
LEO Pharma A/S, founded in 1908, is an independent research-based pharmaceutical company. The Company develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients in more than 100 countries globally. It supplies medicines and solutions to patients suffering from skin infections and diseases such as psoriasis, acne and eczema, as well as conditions that require supportive treatments such as thrombosis, kidney disease and cancer. The Company is wholly owned by the LEO Foundation.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202212/31/2022Yes---Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman, Board of Directors Jukka PekkaPertola
President and Chief Executive Officer GitteAabo
Executive Vice President, Global Research & Development AndersKronborg
Executive Vice President, US & President & CEO of LEO Pharma, Inc. ChrisPosner

Subsidiaries
Business Name Address City State/Province Country
Peplin Inc (Chess) 6475 Christie Avenue Emeryville CA United States
Peplin, Inc. 6475 Christie Avenue Emeryville CA United States

Business Names
Business Name
Laboratoires LEO S.A.
Laboratorios LEO Pharma S.A.
LEO Farmacuticos Lda.
28 additional Business Names available in full report.

General Information
Number of Employees: 5,820 (As of 12/31/2019)
Fax Number: +45 7226-3321


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024